<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20200714048104N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-08-29</date_registration>
      <primary_sponsor>Shahid Beheshti University of Medical Sciences</primary_sponsor>
      <public_title>partnership-based education and adherence to the treatment plans</public_title>
      <acronym></acronym>
      <scientific_title>The effect of partnership-based education on adherence to the treatment plans of patients undergoing open heart surgery</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-07-04</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>86</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/49898</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Education/Guidance, Randomization description: The random assignment sequence and list of blocks will be obtained using R software. The block method is used for sampling. According to the total number of samples required for the study, which is 86 patients (43 patients in the intervention group (A) and 43 patients in the control group (B)), 21 blocks with a size of four includes two groups A and B will be randomly selected using the software, such as (ABAB). Then 86 pockets (43 pockets A and 43 pockets B) will be prepared. According to a list of blocks, a trained person outside the research team is responsible for randomly assigning patients. After admission of each patient to the intensive care unit, will be given a pocket and assigned to Group A (intervention) or B (control group), and the sample process will be performed sequentially until the end of completion of sample size, Blinding description: Due to the nature of the study, it is not possible to blind participants and implement the intervention. But, the collection of demographic information and adherence of therapeutic plan assessment questionnaires (outcome assessment) are performed before and after the intervention by a trained nurse outside the research team and data analyst will not be aware of  the assignment of individuals to groups.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Cardiac disease.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: The intervention includes education with partnership-based approach that will consist of 5 sessions including two sessions of individual training and three sessions of group training for (20 to 45) minutes.The first session includes individual training with the presence of the patient and the caregiver. The duration of the first session will be between 20 and 35 minutes, and information about the type of surgery, the necessary preparations before surgery, the reason for transfer to the ICU, the duration of hospitalization in the intensive care unit, the reason for using connections such as chest tubes and pacemakers , Will be given to them face to face with a focus on questions and answers. Then, three group training sessions (30 to 45 minutes) after transferring the patient to the post-ICU ward with the presence of patients and caregivers will be done in groups of 4 to 6 people. Group educations are speech-based with PowerPoint slides, group discussion, questions and answers and practical presentations.  The content of the educations include the importance of medication regimen after surgery, the role of the proper diet after surgery, start time of the chest physiotherapy program, exercises, time to start sexual activity and the need to participate in a cardiac rehabilitation program. The last session is an individual training session (20 to 25 minutes) for each patient with the caregiver and the content of the education includes a description of the schedule of subsequent referrals after discharge and taking into account the warning signs and early and delayed complications after surgery, how to deal with these complications and referring to the hospital for a quick follow-up, necessary periodical tests, at the end, educational booklet and medication pamphlet were given to the participants. Intervention 2: Control group: The control group uses routine hospital training and in order to observe ethics in research, the control group participants received a booklet and educational pamphlet.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Data analysis information

When:
After the publication of the article

To whom:
Nursing researchers and students

Conditions:
It has not been decided yet

Where to obtain:
Email  to nedasanaie@sbmu.ac.ir

How to obtain:
Email to nedasanaie@sbmu.ac.ir

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Neda Sanaie</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Opposite to Rajaee Heart Hospital,Cross of Vali-Asr and Hashemi Rafsanjani Highway,Vali-Asr Avenue, Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1996835119</zip>
        <telephone>+98 21 8865 5366</telephone>
        <email>nedasanaie@sbmu.ac.ir</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Foroozan Atashzadeh-Shoorideh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Opposite to Rajaee Heart Hospital,Cross of Vali-Asr and Hashemi Rafsanjani Highway,Vali-Asr Avenue,  Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1996835119</zip>
        <telephone>+98 21 8865 5366</telephone>
        <email>f_atashzadeh@sbmu.ac.ir</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients undergoing non-emergency coronary artery bypass graft surgery and valve replacement surgery
Performing open heart surgery for the first time
Ability to read of educational booklet
Ability to attend physically in the educational sessions
Possibility of telephone access to follow up program
First-degree members of the patient who are in close contact with him / her and who are responsible for caring for the patient after discharge from the hospital
Have a minimum literacy rate</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Previous experience of caring for a patient undergoing heart surgery for a family member
known mental illness</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>I51.6</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Cardiovascular disease, unspecified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Other</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: The intervention includes education with partnership-based approach that will consist of 5 sessions including two sessions of individual training and three sessions of group training for (20 to 45) minutes.The first session includes individual training with the presence of the patient and the caregiver. The duration of the first session will be between 20 and 35 minutes, and information about the type of surgery, the necessary preparations before surgery, the reason for transfer to the ICU, the duration of hospitalization in the intensive care unit, the reason for using connections such as chest tubes and pacemakers , Will be given to them face to face with a focus on questions and answers. Then, three group training sessions (30 to 45 minutes) after transferring the patient to the post-ICU ward with the presence of patients and caregivers will be done in groups of 4 to 6 people. Group educations are speech-based with PowerPoint slides, group discussion, questions and answers and practical presentations.  The content of the educations include the importance of medication regimen after surgery, the role of the proper diet after surgery, start time of the chest physiotherapy program, exercises, time to start sexual activity and the need to participate in a cardiac rehabilitation program. The last session is an individual training session (20 to 25 minutes) for each patient with the caregiver and the content of the education includes a description of the schedule of subsequent referrals after discharge and taking into account the warning signs and early and delayed complications after surgery, how to deal with these complications and referring to the hospital for a quick follow-up, necessary periodical tests, at the end, educational booklet and medication pamphlet were given to the participants.</i_keyword>
      <i_keyword>Control group: The control group uses routine hospital training and in order to observe ethics in research, the control group participants received a booklet and educational pamphlet</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Adherence to dietary plan. Timepoint: Before intervention and 8 weeks after end of intervention. Method of measurement: questionnaire of adherence to dietary plan.</prim_outcome>
      <prim_outcome>Adherence to physical activity plan. Timepoint: Before intervention and 8 weeks after end of intervention. Method of measurement: questionnaire of adherence to physical activity plan.</prim_outcome>
      <prim_outcome>Adherence to medication plan. Timepoint: Before intervention and 8 weeks after end of intervention. Method of measurement: standard 8-item Morisky Medication Adherence scale (MMAS-8).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahid Beheshti University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-04-30</approval_date>
        <contact_name>Ethics committee of Shahid Beheshti University of Medical Sciences</contact_name>
        <contact_address>Next to Ayatollah Taleghani Hospital, Shahid Arabi St, Yemen St, Shahid Chamran Highway, Tehran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
